Internal Medicine, Interventional Cardiology · Los Angeles, CA
NPI
1932218666
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8635 W 3rd St, Suite 750w
Los Angeles, CA, 90048
Phone (310) 659-2030
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
27,835 services
Medicare patients, 2024
850
Average age 79
Drug cost, 2024
$1.1M
7,887 prescriptions
Company payments, 2025
$425
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay N Schapira was code 99215 (office e&m - established), 2,987 times for 661 patients. In total Jay N Schapira billed 27,835 services in 137 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 2,987 | 661 | $145.57 | $435K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 2,156 | 491 | $117.60 | $254K |
| 93000 Electrocardiogram | Office | 1,459 | 660 | $12.31 | $18K |
| 99091 E&M - Miscellaneous | Office | 1,288 | 163 | $45.08 | $58K |
| 36415 Venipuncture Blood Collection | Office | 1,206 | 565 | $8.64 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,146 | 506 | $13.87 | $16K |
| 99213 Office E&M - Established | Office | 1,122 | 484 | $77.44 | $87K |
| 99214 Office E&M - Established | Office | 961 | 497 | $100.26 | $96K |
| 85025 Blood Count | Office | 946 | 473 | $7.60 | $7,190 |
| 80048 Clinical Chemistry | Office | 779 | 431 | $8.28 | $6,448 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 774 | 191 | $4.35 | $3,370 |
| 80076 Clinical Chemistry | Office | 730 | 421 | $8.00 | $5,837 |
| 93356 Echocardiography (TTE/TEE) | Office | 572 | 478 | $33.71 | $19K |
| 93978 Duplex Scan - Extremity Arteries | Office | 567 | 478 | $152.98 | $87K |
| 84443 Clinical Chemistry | Office | 561 | 389 | $16.43 | $9,215 |
By year: 2022 $1.8M for 15,858 services; 2023 $1.9M for 20,842 services; 2024 $2.3M for 27,835 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,206 | 565 | $8.64 | $10K |
| 85025 Blood Count | 946 | 473 | $7.60 | $7,190 |
| 80048 Clinical Chemistry | 779 | 431 | $8.28 | $6,448 |
| 80076 Clinical Chemistry | 730 | 421 | $8.00 | $5,837 |
| 84443 Clinical Chemistry | 561 | 389 | $16.43 | $9,215 |
| 84439 Clinical Chemistry | 526 | 369 | $8.83 | $4,643 |
| 82306 Clinical Chemistry | 435 | 334 | $28.98 | $13K |
| 80061 Clinical Chemistry | 405 | 295 | $13.11 | $5,308 |
| 83036 Blood Count | 380 | 286 | $9.51 | $3,614 |
| 83880 Clinical Chemistry | 379 | 234 | $38.47 | $15K |
Medicare prescription drug claims, 2024
In 2024, the drug Jay N Schapira prescribed most often to Medicare patients was Atorvastatin Calcium, with 480 prescriptions and refills. In total Jay N Schapira wrote 7,887 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 480 | 1,264 | 142 | $5,200 |
| Metoprolol Succinate Generic | 419 | 1,015 | 124 | $6,940 |
| Rosuvastatin Calcium Generic | 376 | 1,022 | 119 | $5,822 |
| Telmisartan Generic | 366 | 889 | 101 | $13K |
| Amlodipine Besylate Generic | 351 | 937 | 113 | $3,448 |
| Eliquis Apixaban | 286 | 471 | 67 | $273K |
| Clopidogrel Clopidogrel Bisulfate | 228 | 616 | 71 | $3,391 |
| Levothyroxine Sodium Generic | 209 | 525 | 67 | $2,268 |
| Losartan Potassium Generic | 176 | 463 | 54 | $2,056 |
| Potassium Chloride Generic | 173 | 372 | 55 | $3,681 |
| Furosemide Generic | 164 | 390 | 54 | $1,078 |
| Pravastatin Sodium Generic | 152 | 376 | 45 | $2,122 |
| Repatha Sureclick Evolocumab | 148 | 233 | 29 | $129K |
| Famotidine Generic | 147 | 323 | 47 | $2,027 |
| Ezetimibe Generic | 133 | 349 | 41 | $4,047 |
Brand drugs: 1,330 claims; generic drugs: 6,542 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay N Schapira $425 ($425 in general payments such as food, travel and fees) from 6 companies. The largest payer was Medtronic, Inc. with $168.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.